Le Lézard
Classified in: Health
Subjects: MAV, BLK, CFG, DEI

/R E P E A T -- NOTICE TO THE MEDIA - Government of Canada to announce funding to support the mental health of Black communities/


TORONTO, Feb. 23, 2023 /CNW/ - The Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health accompanied by the Honourable Marci Ien, Minister for Women and Gender Equality and Youth, will announce support to mental health programs for Black communities.  

There will be a media availability immediately following the announcement. 

Media may attend the announcement either in person or via Zoom.

Date 
February 24, 2023

Time 
9:30 a.m (EST)

Location

The event will be held in-person at:

Wanasah: Mental Health Services for Black Youth
660 Dundas Street East
3rd Floor, Unit 4
Toronto, Ontario   M5A 0R3

Masks are recommended.

Media may also join by Zoom:
https://hc-sc-gc-ca.zoom.us/j/67258181803
Passcode:  230224

Please indicate your name (first and last) and media outlet when joining the event.

Twitter: @GovCanHealth
Facebook: Healthy Canadians

SOURCE Health Canada


These press releases may also interest you

at 02:00
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...

at 01:54
FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6)Net sales SEK 257.2 M (230.2)Operating profit SEK 45.8 M (23.7)Profit after tax SEK 36.7 M (17.6)Earnings per share before/after dilution SEK 1.07 (0.51)Cash flow SEK 87.9 M...

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...



News published on and distributed by: